Linking the reversal of gestational insulin resistance to postpartum depression.

Linking the reversal of gestational insulin resistance to postpartum depression.

Publication date: Oct 08, 2024

Postpartum depression (PPD) constitutes a significant mental health disorder affecting almost one fifth of pregnancies globally. Despite extensive research, the precise etiological mechanisms underlying PPD remain elusive. However, several risk factors like genetic predisposition, hormonal fluctuations, and stress-related environmental and psychosocial triggers have been found to be implicated in its development. MAIN: Recently, an increased risk of PPD has been reported to be associated with gestational diabetes mellitus (GDM), which is characterized by the disruption of glucose metabolism, primarily attributed to the emergence of insulin resistance (IR). While IR during pregnancy seems to be an evolutionary adaptative mechanism to handle the profound metabolic alterations during pregnancy, its subsequent resolution following delivery necessitates a reconfiguration of the metabolic landscape in both peripheral tissues and the central nervous system (CNS). Considering the pivotal roles of energy metabolism, particularly glucose metabolism, in CNS functions, we propose a novel model that such pronounced changes in IR and the associated glucose metabolism seen postpartum might account for PPD development. This concept is based on the profound influences from insulin and glucose metabolism on brain functions, potentially via modulating neurotransmitter actions of dopamine and serotonin. Their sudden postpartum disruption is likely to be linked to mood changes, as observed in PPD. The detailed pathogenesis of PPD might be multifactorial and still remains to be fully elucidated. Nevertheless, our hypothesis might account in part for an additional etiological factor to PPD development. If our concept is validated, it can provide guidance for future PPD prevention, diagnosis, and intervention.

Open Access PDF

Concepts Keywords
Diabetes Depression, Postpartum
Environmental Diabetes, Gestational
Extensive Female
Postpartum Glucose
Psychosocial Humans
Insulin
Insulin Resistance
Insulin resistance (IR)
Postpartum depression (PPD)
Pregnancy
Pregnancy

Semantics

Type Source Name
disease MESH insulin resistance
pathway KEGG Insulin resistance
disease MESH postpartum depression
drug DRUGBANK p-Phenylenediamine
disease MESH gestational diabetes mellitus
pathway REACTOME Glucose metabolism
pathway REACTOME Metabolism
drug DRUGBANK Dopamine
drug DRUGBANK Serotonin
disease MESH pathogenesis
pathway REACTOME Reproduction
disease MESH depression
disease MESH mental disorder
drug DRUGBANK Dextrose unspecified form
disease MESH morbidity
disease MESH suicide
drug DRUGBANK Progesterone
drug DRUGBANK Hydrocortisone
disease MESH mood disorders
disease MESH major depressive disorders
disease MESH anxiety
pathway REACTOME Release
drug DRUGBANK ATP
disease MESH tryptophan
drug DRUGBANK L-Tryptophan
drug DRUGBANK Glutamic Acid
drug DRUGBANK Isoxaflutole
disease MESH sleep deprivation
disease MESH ketosis
drug DRUGBANK Coenzyme M
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Oxytocin
disease MESH brain disease
drug DRUGBANK Gold
disease MESH atrophy
disease MESH obesity
disease MESH diabetes mellitus
drug DRUGBANK Semaglutide
pathway KEGG Insulin secretion
disease MESH gestational weight gain
drug DRUGBANK Silver

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *